{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:21:17Z","timestamp":1792239677118,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":53,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005194.pub2","type":"reference-entry","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T20:38:24Z","timestamp":1153255104000},"source":"Crossref","is-referenced-by-count":84,"title":["Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings"],"prefix":"10.1002","author":[{"given":"Cecile","family":"Denis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Fatseas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Auriacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"10.1002\/14651858.CD005194.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1192\/bjp.156.3.406","article-title":"Chronic benzodizepine dependence. A comparative study of abrupt withdrawal under propanolol cover versus gradual withdrawal","volume":"156","author":"Cantopher","year":"1990","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005194.pub2-BIB2|cit2","first-page":"40","article-title":"The treatment of tranquillizer dependence by propanolol","volume":"64","author":"Hallstr\u00f6m","year":"1988","journal-title":"Postgraduate Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD005194.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004714-198702000-00003","article-title":"A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms","volume":"7","author":"Lader","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005194.pub2-BIB4|cit4","first-page":"290","article-title":"Withdrawal of long-term administered lorazepam using 6 different plans. A placebo controlled study.","volume":"23","author":"Lemoine","year":"1997","journal-title":"Enc\u00e9phale"},{"key":"10.1002\/14651858.CD005194.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.158.4.511","article-title":"A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence","volume":"158","author":"Murphy","year":"1991","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005194.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1991.01810290060012","article-title":"Carbamazepin treatment in patients discontinuing long-term benzodiazepine therapy. effects on withdrawal severity and outcome","volume":"48","author":"Schweizer","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005194.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02246214","article-title":"Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome","volume":"117","author":"Schweizer","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD005194.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1192\/bjp.168.4.457","article-title":"A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms","volume":"168","author":"Tyrer","year":"1996","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005194.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1192\/bjp.157.2.232","article-title":"A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users","volume":"157","author":"Ashton","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005194.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1360-0443.1994.tb03755.x","article-title":"The treatment of benzodiazepine dependence","volume":"89","author":"Ashton","year":"1994","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD005194.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004714-198912000-00005","article-title":"A clinical scale to assess benzodiazepine withdrawal","volume":"9","author":"Busto","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD005194.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/clpt.1994.55","article-title":"Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans","volume":"55","author":"Busto","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD005194.pub2-BIB13|cit13","first-page":"35","article-title":"Safety of ipsapirone treatment compared with lorazepam: discontinuation effects","volume":"23","author":"Busto","year":"1998","journal-title":"Journal of Psychiatry and Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD005194.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0011-393X(05)80679-4","article-title":"Effectiveness of flumazenil (Ro 15-1788) in the treatment of benzodiazepine withdrawal","volume":"54","author":"Gerra","year":"1993","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD005194.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/1355621021000005973","article-title":"Intrvenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study","volume":"7","author":"Gerra","year":"2002","journal-title":"Addiction Biology"},{"issue":"7","key":"10.1002\/14651858.CD005194.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.143.7.900","article-title":"Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases","volume":"143","author":"Goodman","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005194.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF02246023","article-title":"Changes in \"withdrawal symptoms\" following discontinuation of low-dose diazepam","volume":"125","author":"Hayward","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005194.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004850-199300810-00005","article-title":"A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms","volume":"8","author":"Lader","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"issue":"9 & 10","key":"10.1002\/14651858.CD005194.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1081\/JA-100106224","article-title":"Evaluation of programs for the treatment of benzodiazepine dependency","volume":"36","author":"Lilja","year":"2001","journal-title":"Substance Use and Misuse"},{"key":"10.1002\/14651858.CD005194.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/09595230100100615","article-title":"In-patient benzodiazepine withdrawal: comparison of fixed and syptom- triggered taper methods","volume":"22","author":"McGregor","year":"2003","journal-title":"Drug and Alcohol Review"},{"issue":"9","key":"10.1002\/14651858.CD005194.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1185\/030079904125004457","article-title":"The role of captodiamine in the withdrawal from long-term benzodiazepine treatment","volume":"20","author":"Mercier-Guyon","year":"2004","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s002130051161","article-title":"A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users","volume":"147","author":"Mintzer","year":"1999","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10826088609063450","article-title":"Alternative treatments for withdrawing the long-term benzodiazepine user: a pilot study","volume":"21","author":"Nathan","year":"1986","journal-title":"The International Journal of the Addictions"},{"key":"10.1002\/14651858.CD005194.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long term use of benzodiazepines. Effects of abrupt discontinuation","volume":"47","author":"Rickels","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004714-199804000-00004","article-title":"A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation","volume":"18","author":"Romach","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005194.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1360-0443.1987.tb00434.x","article-title":"Cognitive-behavioural treatment for benzodiazepine dependence: a comparison of gradual versus abrupt cessation of drug intake","volume":"82","author":"Sanchez-Craig","year":"1987","journal-title":"British Journal of Addiction"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002130000574","article-title":"Gender-related differences in response to placebo in benzodiazepine withdrawal: a single-blind pilot study","volume":"153","author":"Saxon","year":"2001","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD005194.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130050278","article-title":"Effects of flumazenil in the treatment of benzodiazepine withdrawal: a double-blind pilot study","volume":"131","author":"Saxon","year":"1997","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD005194.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1176\/ajp.143.12.1590","article-title":"Failure of buspirone to manage benzodiazepine withdrawal","volume":"143","author":"Schweizer","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD005194.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1001\/archpsyc.1990.01810220024003","article-title":"Long-term use of benzodiazepines. Effects of gradual taper","volume":"47","author":"Schweizer","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"8436","key":"10.1002\/14651858.CD005194.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(85)91638-1","article-title":"Psychological treatment for benzodiazepine dependence","volume":"1","author":"Tyrer","year":"1985","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005194.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004060170045","article-title":"A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects","volume":"251","author":"Voderhorlzer","year":"2001","journal-title":"European Archives of Psychiatry and Clinical Neurosciences"},{"issue":"7","key":"10.1002\/14651858.CD005194.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1360-0443.2002.00129.x","article-title":"Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches","volume":"97","author":"Vorma","year":"2002","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD005194.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0376-8716(03)00014-0","article-title":"Long-term outcome after benzodiazepine withdrawal treatment in subjects with complicated dependence","volume":"70","author":"Vorma","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD005194.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.182.6.498","article-title":"Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial","volume":"182","author":"Voshaar","year":"2003","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005194.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050798","article-title":"Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome","volume":"141","author":"Rickels","year":"1999","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB37|cit37","first-page":"117","article-title":"A randomised, multicentre, double-blind, comparison of atenolol and placebo in the control of benzodiazepine withdrawal symptoms","volume":"15","author":"Saul","year":"1989","journal-title":"Acta Therapeutica"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB38|cit38","first-page":"104","article-title":"Benzodiazepine abuse in a methadone maintenance treatment clinic in Isrrael: characteristics and a pharmacotherapeutic approach","volume":"39","author":"Bleich","year":"2002","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"14","key":"10.1002\/14651858.CD005194.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1056\/NEJM198610023151403","article-title":"Withdrawal reaction after long-term therapeutic use of benzodiazepines","volume":"315","author":"Busto","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005194.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.04.002","article-title":"Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome","volume":"76","author":"Wet","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD005194.pub2-BIB41|cit41","volume-title":"Diagnostical and Statistical Manual of Mental Disorders","year":"1994"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0447.1997.tb09911.x","article-title":"High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria","volume":"96","author":"Kan","year":"1997","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD005194.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1360-0443.1998.9333494.x","article-title":"An evaluation of DSM-III-R and ICD-10 benzodiazepine dependence criteria using Rasch modelling","volume":"93","author":"Kan","year":"1998","journal-title":"Addiction"},{"issue":"7","key":"10.1002\/14651858.CD005194.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1360-0443.1991.tb01831.x","article-title":"Benzodiazepine problems","volume":"86","author":"Lader","year":"1991","journal-title":"British Journal of Addiction"},{"issue":"11","key":"10.1002\/14651858.CD005194.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5694\/j.1326-5377.1986.tb112319.x","article-title":"Treatment of benzodiazepine dependence","volume":"144","author":"Lennane","year":"1986","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1002\/14651858.CD005194.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0024-3205(82)90697-X","article-title":"Diazepam and pentobarbital dependence in the rat","volume":"31","author":"Martin","year":"1982","journal-title":"Life Science"},{"issue":"24","key":"10.1002\/14651858.CD005194.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/jama.1995.03530240072044","article-title":"Meta-analysis of randomized controlled trials. A concern for standards","volume":"274","author":"Moher","year":"1995","journal-title":"JAMA"},{"issue":"6292","key":"10.1002\/14651858.CD005194.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.283.6292.643","article-title":"Withdrawal from long-term benzodiazepine treatment","volume":"283","author":"Petursson","year":"1981","journal-title":"British Medical Journal of Clinical research and Education"},{"key":"10.1002\/14651858.CD005194.pub2-BIB49|cit49","first-page":"767","article-title":"Long-term diazepam therapy and clinical outcome","volume":"6","author":"Rickels","year":"250","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD005194.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpsyc.1988.01800290060008","article-title":"Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone","volume":"45","author":"Rickels","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB51|cit51","first-page":"151","article-title":"Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper","volume":"148","author":"Salzman","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005194.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archpsyc.1980.01780140103012","article-title":"Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study","volume":"37","author":"Winokur","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005194.pub2-BIB53|cit53","first-page":"155","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacological Review"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005194.pub3","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"record-id":"33038"},{"DOI":"10.1002\/14651858.cd005194.pub3","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005194.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:46:13Z","timestamp":1628545573000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005194.pub2"}},"subtitle":[],"editor":[{"given":"Cecile","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005194.pub2","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD005194.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,7,19]]}}}